Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment
4 April 2022 (13:40 - 13:47)
Organised by:
About the speaker
The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
5 More presentations in this session
Doctor M. Gawalko (Warsaw, PL)
Doctor B. Ratajczak-Tretel (Sarpsborg, NO)
Doctor P. Rasmussen (Copenhagen, DK)
Access the full session
The Event
EHRA 2022
4 April 2022
13:40 CET
